Counterpart Health released key 2025 highlights. The past year was defined by continued publication of research demonstrating the platform’s impact on chronic disease management, meaningful product expansion, and the scaled adoption of Counterpart Assistant by hundreds of live third-party customer clinicians across diverse practice settings. Data released in 2025 highlights the scale and consistency of the platform’s impact. These outcomes reflect the cumulative effect of thousands of better clinical decisions made during real patient visits: Clinician Adoption: Counterpart recorded a greater than450% Year-over-Year increase in live third-party customer clinicians, now representing hundreds of third-party customer clinicians live on the platform across multiple states. MCR Differential: Returning Clover Health (CLOV) members whose primary care physicians use CA demonstrated an approximate 1,500 basis point MCR differential compared to those whose PCPs do not, with performance differentials compounding as member cohorts mature. Quality Metrics: Counterpart’s technology supported the #1 HEDIS score nationwide for a PPO Medicare Advantage plan for the second consecutive year-achieved across a wide network of non-employed physicians without capitation.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV:
